Lundbeck says cancer drug approved in Canada
COPENHAGEN Aug 28 (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had received approval from Health Canada for its cancer treatment Treanda which is used to treat two common types of cancer including lymphocytic leukaemia.
Lundbeck said the move would substantially strengthen the group's growth outlook, but kept its full-year guidance intact.
It said it expected Treanda would be available to physicians and patients in Canada during September.
(Reporting by Mette Fraende; Editing by Dan Lalor)
- Tweet this
- Share this
- Digg this
- UPDATE 3-Avalanche kills at least 12 guides in deadliest incident on Mount Everest
- UPDATE 10-Vice-principal of South Korea school in ferry disaster commits suicide
- Avalanche kills at least 12 guides in deadliest incident on Mount Everest
- India passes halfway mark in election with BJP gaining strength
- Vice-principal of South Korea school in ferry disaster commits suicide